Your browser doesn't support javascript.
loading
Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.
Zhu, Guoliang; Wang, Miao; Kong, Fanyi.
Affiliation
  • Zhu G; Department of Neurology, The Affiliated Hospital of Yunnan University, Kunming, P. R. China.
  • Wang M; School of Clinical Medicine, Dali University, Dali, P. R. China.
  • Kong F; Department of Neurology, West China Hospital, Sichuan University, Chengdu, P. R. China.
Headache ; 64(5): 573-588, 2024 05.
Article de En | MEDLINE | ID: mdl-38659322
ABSTRACT

OBJECTIVE:

We conducted a systematic review and meta-analysis to explore the relationship between blood pituitary adenylate cyclase-activating polypeptide (PACAP) levels and migraine.

BACKGROUND:

PACAP is involved in the onset of migraine, but the results from clinical studies on PACAP level variations across different periods of migraine are conflicting.

METHODS:

We systematically searched for observational studies that reported PACAP levels in people with migraine and non-migraine controls published in English from the PubMed, Web of Science, and Ovid electronic databases, or in Chinese from the Chinese National Knowledge Infrastructure and the WanFang Med database. The Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of the included studies. The quality of evidence for each outcome was assessed according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidelines.

RESULTS:

Of the 514 identified studies, 8 were eligible for inclusion. There was a "very low" level of evidence suggesting that the PACAP level is negatively correlated with migraine disease duration in adults with migraine (summary r = -0.35, 95% confidence interval [CI] -0.49 to -0.22) and that the PACAP is higher in people with migraine during the ictal period than in the interictal period (standardized mean difference = 0.41, 95% CI 0.17 to 0.66) for both adults and children with migraine. Adult patients with episodic migraine (weighted mean difference [WMD] = -9.58 pg/mL, 95% CI -13.41 to -5.75 pg/mL) or chronic migraine (WMD = -10.93 pg/mL, 95% CI -15.57 to -6.29 pg/mL) had lower blood PACAP levels than non-migraine controls during the interictal period, supported by a "low" or "very low" quality of evidence, respectively, according to the GRADE rules.

CONCLUSION:

There is a very low certainty of evidence suggesting that the PACAP level is negatively correlated with migraine disease duration of adults with migraine and it varies greatly among different periods of migraine of both adults and children with migraine.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Études observationnelles comme sujet / Polypeptide activateur de l'adénylcyclase hypophysaire / Migraines Limites: Humans Langue: En Journal: Headache Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Études observationnelles comme sujet / Polypeptide activateur de l'adénylcyclase hypophysaire / Migraines Limites: Humans Langue: En Journal: Headache Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique